Post on 02-Aug-2020
transcript
Research Article CODEN: IJPRNK IMPACT FACTOR: 4.278 ISSN: 2277-8713 Amir Ibrahim Mohamed, IJPRBS, 2014; Volume 3(5): 177-193 IJPRBS
Available Online at www.ijprbs.com 177
GLYCERYL MONO OLEATE CUBOSOME / CA-ALGINATE MICROPARTICULATE
SYSTEM: A NEW MATRIX TO IMPROVE THE RELEASE PROPERTIES OF A WATER-
SOLUBLE MODEL DRUG
AMIR IBRAHIM MOHAMED1, OSAMA A. A. AHMED2, SUZAN AMIN3, OMAR ANWAR ELKADI4,
MOHAMED A. KASSEM5
1. Lecturer, Military Medical Academy, Cairo, Egypt. 2. Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia. 3. Medical services Department, Cairo, Egypt. 4. Faculty of Pharmacy, Cairo University, Egypt. 5. Department of Pharmaceutics, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
Accepted Date: 11/09/2014; Published Date: 27/10/2014
Abstract: Objective: Alginate polymers suffer from rapid release of water soluble drugs in physiologic salt concentration. In this study, a new microsphere delivery system composed of GMO-cubosome embedded in Ca-alginate was designed to improve the release properties of a water-soluble model drug (Clindamycin). Methods: GMO-alginate based microspheres were prepared by w/o emulsion method, and formulation variables such as alginate molecular weight, concentration, surfactant ratio, and homogenization speed were fixed, while alginate:GMO ratio and drug concentration were investigated. Results: Alginate:GMO ratio significantly affected the particle size and morphology. Microparticles with low GMO contents (1:0.25) were spherical in shape with average diameter of 35.2 μm, with increasing GMO contents (1:0.5 to 1:1), microparticles become more flattened, collapsed and larger in size. Degradation study revealed that the erosion of microspheres decreased significantly by GMO-cubosomes addition as compared to blank Ca-alginate microspheres. 50% weight loss was reached at approximately 8hrs for 1:0.25 GMO containing microspheres as compared to 5.5hrs for blank microspheres without cubosomes, indicating that the presence of cubosomes increased the stability of Ca-alginate microspheres. Additionally, the extent of Clindamycin release from the Alginate:GMO(1:0.25) microspheres was 47% lower than the release from the conventional microspheres. Conclusions: These novel microparticles have a uniform structure, confined size distribution, satisfactory entrapment efficiency, and acceptable sustained release properties.
Keywords: Glyceryl mono-oleate (GMO); Cubosome dispersion; Ca-alginate; Clindamycin Hcl; Sustained release
microspheres; Water-soluble drug.
INTERNATIONAL JOURNAL OF
PHARMACEUTICAL RESEARCH AND BIO-SCIENCE
PAPER-QR CODE
Corresponding Author: DR. AMIR IBRAHIM MOHAMED
Access Online On:
www.ijprbs.com
How to Cite This Article:
Amir Ibrahim Mohamed, Osama A. A. Ahmed, Suzan Amin, Omar Anwar
Elkadi, Mohamed A. Kassem; IJPRBS, 2014; Volume 3(5): 177-193
Research Article CODEN: IJPRNK IMPACT FACTOR: 4.278 ISSN: 2277-8713 Amir Ibrahim Mohamed, IJPRBS, 2014; Volume 3(5): 177-193 IJPRBS
Available Online at www.ijprbs.com 178
INTRODUCTION
Lipids of various types have been extensively studied for drug delivery by different routes of
administration. Polar amphiphilic lipids such as glyceryl mono-oleate (GMO) Figure (1a) when
placed in water spontaneously forms thermodynamically stable lipid bilayers, and three types
of liquid crystalline phases (lamellar, reversed hexagonal and cubic phase) depending upon the
temperature and water content [1]. GMO–water cubic phase dispersions (Cubosomes) are
usually produced by combining water (concentrations from 55 to 85%) with 15–45% GMO at 40
°C. Then, the resultant cubic liquid crystalline gel is dispersed into particles via the application
of mechanical or ultrasonic energy. Finally, the cubosomes are stabilized against flocculation by
stabilizer poloxamer 407 (Pluronic F127) additions [2]. Structure of the cubic phase is unique
and consists of a curved bicontinuous lipid bilayer extending in three dimensions, separating
two congruent networks of water channels Figure (1c). The water pore diameter of the fully
swelled phase is about 5 nm and the phase is very viscous [1].
Monoglycerides are used in many food applications such as in bread and cake production for
improvement of shelf life and flavour retention [3]. The particular properties of monoglyceride-
based cubic phases, temperature stability, bicontinuous structure, high internal surface area,
and low cost raw materials, make them desirable for personal cure product and pharmaceutical
industry applications [4]. In addition, the stiffness and high viscosity make the GMO–water
cubic phase an excellent in situ forming biodegradable matrix type drug delivery system with
varying molecular weights and solubilities in water, such as Aspirin, vitamin E, Oxybutynine
hydrochloride, Metronidazole, Tetracycline, Timolol maleate, Chlorpheniramine maleate,
Propranolol HCl, Melatonin, and Haemoglobin [1]. Cubosomes have been shown to have a high
efficiency in entrapping antigens as well as providing extended antigen release. Sustain release
over an extended period of time may reduce the need for multiple vaccination, which will be a
benefit in terms of reduced costs and increased patient compliance [5]. Finally, bio-adhesive
nature of GMO cubic dispersion was found to be a gastro-retentive carrier system suitable for
both polar and as well as non-polar drugs. Cubic nanoparticles significantly enhanced oral
bioavailabity of Simvastatin, Cyclosporine, and Silymarin [6]. GMO formulations undergo
digestion in the gastrointestinal tract where ester bond of GMO is rapidly cleaved by pancreatic
lipase during the digestion to form oleic acid and glycerol [7].
Clindamycin [7(S)-chloro-7-deoxylincomycin] is a water soluble anti-biotic drug Figure (1d). It is
synthesized from microbially fermented lincomycin by replacing a hydroxyl group at the 7-
position of lincomycin by a chlorine group which significantly increases its activity [8].
Clindamycin is highly effective against Gram-positive and Gram-negative anaerobic pathogens,
as well as Gram-positive aerobes, the primary effect is exerted by its binding to the 50S
ribosomal subunit and the consequent inhibition of bacterial protein synthesis [9]. Clindamycin
is widely distributed throughout the body and has an average biological
Research Article CODEN: IJPRNK IMPACT FACTOR: 4.278 ISSN: 2277-8713 Amir Ibrahim Mohamed, IJPRBS, 2014; Volume 3(5): 177-193 IJPRBS
Available Online at www.ijprbs.com 179
half-life of 2.4 h. The major bioactive metabolites excreted in urine and feces are clindamycin
sulfoxide and N-desmethylclindamycin [10]. Clindamycin is mainly used in the treatment of
serious respiratory tract infection, serious skin and soft tissue infections, septicemia, intra-
abdominal infections and infections of the female pelvis and genital tract caused by susceptible
anaerobic bacteria [11].
Sodium alginate is a sodium salt of alginic acid, a naturally occurring, anionic, linear non-toxic
polysaccharide found in brown algae consisting of varying ratios of Guluronic and Mannuronic
acid units Figure (1b). Alginate has been widely used as food and pharmaceutical additives, such
as a tablet disintegrate and gelling agent. Alginate delivery systems are formed when
monovalent, water-soluble, salts of Guluronic, and Mannuronic acid residues undergo cross-
linking gelation with divalent cations, such as Ca++ into water-insoluble gel matrix. Each Ca++ ion
takes part in nine co-ordination link with an oxygen atom, resulting in three-dimensional
network of calcium-alginate, the so-called "egg-box" structure Figure (1e) [12, 13]. Alginate
polymers have been widely used in biomedical applications as they are biodegradable and
biocompatible, but suffer from the limitation of rapid drug release in physiologic salt
concentration. In the presence of monovalent (e.g. sodium) salts, insoluble calcium alginate
gets converted into soluble form (sodium alginate), resulting in rapid disintegration of the
delivery system and drug release [14].
Among the different approaches to achieve sustained release drug delivery, the use of
polymers, specifically biodegraded alginate, and monoglycerides holds great promise. In this
work, a new microsphere delivery system composed of GMO-cubosome embedded in Ca-
alginate was designed to improve the release properties of a water-soluble model drug
Clindamycin Hcl.
Figure 1 Molecular structure of the compounds under investigation; (a) Glyceryl mono-oleate
(GMO), (b) Na-alginate, (c) Cubic phase in three dimensions [1,4], (d) Clindamycin, (e) Ionic
interaction between alginate & divalent cations [15].
Research Article CODEN: IJPRNK IMPACT FACTOR: 4.278 ISSN: 2277-8713 Amir Ibrahim Mohamed, IJPRBS, 2014; Volume 3(5): 177-193 IJPRBS
Available Online at www.ijprbs.com 180
MATERIALS AND METHODS
1. Materials
Clindamycin hydrochloride, was purchased from Sigma-Aldrich Chemie GmbH (Riedstrasse,
Germany). Sodium Alginate was purchased from Sas chemicals (Mumbai, India). Monoolein was
obtained from Danisco Emulsifiers (DIMODAN® MO 90/D, Denmark). Sorbitane Monooleate
(Span80) was obtained from Loba Chemie (Mumbai, India). Pluronic© F127 was purchased
from Sigma-Aldrich Chemie (USA). Procine pancreatice lipase (59 IU/mg) was obtained from
AppliChem GmbH (Darmstadt, Germany). Methanol, Iso-propyl alcohol, Dichloromethne (DCM)
of analytical grade, and Calcium chloride dehydrate were purchased from El-Nasr chemicals Co.
(Cairo, Egypt).
2. Methods
2.1. Preparation and Characterization of GMO-Cubic Dispersion
Blank dispersions of GMO were prepared by conventional fragmentation method, which
involves mechanical dispersion of bulk cubic gel in presence of pluronics as stabiliser [4, 16]. In
details; 300mg GMO was weighed into 5mL glass vial, heated to 45 °C in a water bath, then
water (0.7ml) was gently dropped on the surface of lipids, and finally incubated at room
temperature 24hrs to allow formation and equilibration of the cubic gel phase. The resultant
viscous cubic gel was mixed with 1.5ml of 2% Pluronic F127 solution (10:1, GMO: F127 w/w) to
form a coarse dispersion. This dispersion was subsequently homogenised using a microtip
probe sonicator (4mm diameter tip, 25KHz frequency and 30 Watts power output, VCX series,
Sonics, USA) for 2 min at 25 °C. Particle size, morphology, distribution, and polydispersity (PDI)
were determined using Malvern Zetasizer 3000 (Malvern, UK), and Transmission electron
microscope (TEM), JEM-2100F (Jeol, Japan).
2.2. Preparation and Characterization Ca-alginate microspheres
Alginate microspheres were prepared by conventional water-in-oil (W/O) emulsion method
with some modifications [17-19]. Briefly, 10 ml of 4% (w/v) sodium alginate was poured into
250ml rounded bottom glass container which contained 50 ml DCM and 2 ml Span 80, and then
emulsified for 2 min at 15200 rpm using homogenizer. 2cm magnetic bare was placed into the
emulsion and the glass container tightly closed by a rubber closer. Microspheres were prepared
by adding 8 ml of 5% (w/v) CaCl2 (dissolved in 1:2 mixture of methanol and isopropyl alcohol) to
the emulsion drop by drop via 10ml syringe at1000 rpm and stirring for 60 min to assure
efficient cross-linking. In this step, microspheres were formed in suspension. Microsphere
suspension was allowed to stabilize on ice for about 10 min, and the microspheres were
collected by filtration in vacuum, washed with isopropyl alcohol twice and finally dried at room
temperature. The morphology and average particle diameter were characterized by Scanning
c) )
Research Article CODEN: IJPRNK IMPACT FACTOR: 4.278 ISSN: 2277-8713 Amir Ibrahim Mohamed, IJPRBS, 2014; Volume 3(5): 177-193 IJPRBS
Available Online at www.ijprbs.com 181
electron microscope (SEM), (Phnom-ProG2, Netherlands) after samples drying under vacuum,
and observed at 5 KV. For particle size analysis, the diameter of 50-100 particles was measured
and averaged from photos by a computer software (Particlemetric, Phenomworld) came
together with SEM equipment.
2.3. Preparation and Characterization GMO-Ca-alginate microspheres
Different volumes of blank GMO-dispersion were emulsified into 10 ml of 4% (w/v) sodium
alginate solution by vortexing at 1000 rpm (IKA Labortechnik, Germany) for 2 min to get a final
Alginate:GMO w/w ratios of 1:1, 1:0.75, 1:0.5, and 1:0.25. These primary emulsions were
further emulsified into 50 ml DCM/2ml Span 80, and the microspheres were prepared as
described before. The effect of GMO addition on Ca-alginate microspheres shape, size, and
degradation degree was studied then the optimum Alginate:GMO ratio was determined.
2.3.1. Morphology observation
The interior morphology of GMO-loaded Ca-alginate microspheres was examined using
scanning electron microscopy at an accelerating voltage of 5 kV.
2.3.2. In-vitro Degradation study
Degradation degrees of the free Ca-alginate microspheres and GMO-loaded Ca-alginate
microspheres were estimated gravimetrically from mass loss of microspheres (weight
remaining at a specific time relative to initial weight)[20]. In details, 50mg microspheres of each
formulations was placed in individual accurately weighed empty 2ml Eppendorf tube weighted
as We (Electronic Analytical Balance XB 220A, Precesia, Swaziland). 1.5 ml of Phosphate buffer
solution (PBS) (pH 7.4) was added to each tube and allow standing for 1 hour, then PBS was
removed from the Eppendorf tubes by centrifugation at 15000 rpm for 30 minutes (Z326K,
Hermle Labor Technik, Germany) and withdrawn by 3ml syringe. The tube containing swelling
microspheres was weighed as W0. Fresh 1.5 ml of PBS (pH 7.4) was added to each tube and
then all tubes were kept in a thermostated orbital shaker (Stuart, Bibby Scientific, United
Kingdom) that was maintained at 37°C and 100 rpm. At predetermined time intervals, the
degradation medium (PBS) was removed by centrifugation at 15000 rpm for 30 minutes and the
tubes containing microspheres residue were reweighed as Wt , then the degradation degree
calculated as follows:
Degradation % = W0 – Wt / W0 - We X 100 %
Where W0 is the initial swelling microspheres weight, Wt is the residue weight after time t, and
We is the individual Eppendorf tube weight.
New fresh 1.5 ml of PBS was added back to each tube and the experiment was continued until
no residue remained. All tests were performed in triplicate and the mean ±SD was calculated.
Research Article CODEN: IJPRNK IMPACT FACTOR: 4.278 ISSN: 2277-8713 Amir Ibrahim Mohamed, IJPRBS, 2014; Volume 3(5): 177-193 IJPRBS
Available Online at www.ijprbs.com 182
2.4. Preparation and Characterization Drug loaded Ca-alginate microspheres
Serial drug concentrations were used to prepare both Clindamycin-alginate and Clindamycin-
GMO-alginate microspheres. The effect of drug concentration on Ca-alginate microspheres
shape, size, and entrapment efficiency was studied then the optimum Drug:Polymer ratio was
determined.
2.4.1. Clindamycin-alginate microspheres preparation
Microspheres containing 1:0.25, 1:0.5, 1:0.75, 1:1, 1:2, and 1:3 w/w Alginate:Clindamycin ratios
were prepared by dissolving 100, 200, 300, 400, 800, and 1200mg Clindamycin into 10 ml of 4%
(w/v) sodium alginate solution by vortexing for 2 min. These primary mixtures were further
emulsified into 50 ml DCM/2ml Span 80 as described before.
2.4.2. Clindamycin-GMO-alginate microspheres preparation
Using the optimum GMO:Alginate ratio obtained before, the same Alginate:Clindamycin ratios
were prepared by dissolving 100, 200, 300, 400, 800, and 1200mg Clindamycin into 2 ml
distillate water then added to the molten GMO heated to 45 °C in a water bath. The resultant
viscous cubic gel incubated at room temperature 24hrs, mixed with 1.5ml of 2% Pluronic F127
solution, and homogenised using the sonicator for 2 min at 25 °C. Finally, Drug-GMO
dispersions were emulsified into 10 ml of 4% (w/v) sodium alginate solution by vortexing for 2
min and further emulsified into 50 ml DCM as described before.
2.4.3. Microspheres Characterization
The prepared Clindamycin-alginate and Clindamycin-GMO-alginate microspheres were
examined using SEM at an accelerating voltage of 5 kV.
2.4.4. Drug content determination
Accurately weighed 10mg microspheres were added to 10ml phosphate buffer (pH 7.4) in 15ml
falcon tube and left for 24hrs under orbital shaking 150rpm at 37 °C [17]. After 60 min
centrifugation at 6000 rpm, the supernatant liquid was collected and the concentration of
Clindamycin was analyzed by an UV spectrometer (Shumadzu 1700, Japan) against blank of Ca-
alginate microspheres to eliminate any polymer effect. The characteristic absorbance of
Clindamycin at 205 nm was recorded and compared with a standard curve generated from the
Clindamycin concentrations varying from 0 to 0.25mg/mL. The ratio of the actual to the
theoretical drug contents in microspheres was termed as entrapment efficiency. 1ml procine
pancreatice lipase (1500 IU/ml) digestion medium was added into phosphate buffer (pH 7.4) in
case of Clindamycin-GMO-Alginate microspheres to assure complete drug recovery.
Research Article CODEN: IJPRNK IMPACT FACTOR: 4.278 ISSN: 2277-8713 Amir Ibrahim Mohamed, IJPRBS, 2014; Volume 3(5): 177-193 IJPRBS
Available Online at www.ijprbs.com 183
2.5. In-vitro release studies
In vitro drug release from the optimum formulation microspheres was studied using the Dialysis
bag method[21]. 6cm long, 1cm wide dialysis bag molecular weight cut off 12000–14000
(Cellulose tubing membrane, Sigma-Aldrish, USA) was soaked in deionised water for 12hrs
before use. Then, accurately weighed amounts (10mg) of microspheres were filled into the
dialysis bag with the two ends fixed by thread and suspended into 500ml Stoppered Flask
containing 250ml phosphate buffers (pH 1.2, 4.5, and 7.4). The Flask was placed on a magnetic
stirrer (100 rpm) at 37 °C for 2 hrs with pH 1.2 buffer, then dialysis bag transferred into pH 4.5
buffer for another 2hrs, and finally, into pH 7.4 buffer to the end of the experiment. At fixed
time intervals of 30 minutes, 2ml samples were withdrawn and replaced with fresh medium.
The drug content was determined by using a UV Spectrophotometer at a λmax of 205nm
against blank of Ca-alginate microspheres. Since GMO in formulation was assumed to undergo
digestion in the gastrointestinal tract, in-vitro release test for Clindamycin-GMO-Alginate
microspheres was carried out in presence and absence of 1ml procine pancreatice lipase (1500
IU/ml) digestion medium. The measurements were performed triplet for each batch and the
cumulative percent released calculated by summing the drug amount in each sample with the
amounts of previous time point then the total divided by the microspheres drug content.
2.6. Statistical analysis
Tests including in-vitro degradation, entrapment efficiency, and in-vitro release were all
repeated in three separate experiments. Statistical analysis of the difference between each
group was tested by One-way ANOVA (SPSS software), and the results were considered
significant differences when P < 0.05.
RESULTS AND DISCUSSION
Cubosomes are self assemble liquid crystalline particles with a microstructure that provide
unique properties in a size range of 100 nm–10000 nm. There unique structure makes them
biologically compatible and capable to potentially retard release and protect the encapsulated
active against chemical and/or physiological degradation. An attempt has been made in the
present study to improve the controlled release properties of Ca-alginates microspheres using
Glyceryl mono-oleate (GMO) cubic phase dispersions containing a water-soluble model drug;
Clindamycin Hcl.
1. GMO-Cubic Dispersion Characterization
Cubic gel prepared Figure (2a) was clear, highly-viscous gel that does not flow under gravity.
After ultrasonic homogenisation, the resulting average particle size of GMO-dispersions was
between 126 - 150 nm and PDI ranged from 0.51 to 0.55 Figure (2b&c).
Research Article CODEN: IJPRNK IMPACT FACTOR: 4.278 ISSN: 2277-8713 Amir Ibrahim Mohamed, IJPRBS, 2014; Volume 3(5): 177-193 IJPRBS
Available Online at www.ijprbs.com 184
2. Ca-alginate Microsphere characterization
In the preparation of Ca-alginate gel microspheres by w/o emulsion method, the aqueous
emulsion droplets, containing polymer, transformed into solid microsphere upon addition of
CaCl2. The divalent calcium ions are bound in a highly cooperative manner to the guluronic
acids units of the alginate (cross-linking), leading to the formation of water-insoluble gel
particles. A SEM photograph of blank Ca-alginate microspheres was shown in Figure (3). As
seen from the photograph, the microspheres were almost of spherical in shape and have a
rough surface. The average diameter of microspheres was 24.8 μm ± 3.7μm; therefore, the
microspheres were considered an appropriate size for oral drug delivery [19]. This small particle
size was attributable to cooperative consequence of rapid diffusion of the water phase
(including alginate) into the external oil phase and further disrupted into smaller droplets
because of higher rapid homogenization speed [18].
Figure 2Photographs of GMO-Cubic Dispersion preparation; (a) Cubic gel, (b) Cubosome dispersion TEM photo, (c) Particle size distribution.
Research Article CODEN: IJPRNK IMPACT FACTOR: 4.278 ISSN: 2277-8713 Amir Ibrahim Mohamed, IJPRBS, 2014; Volume 3(5): 177-193 IJPRBS
Available Online at www.ijprbs.com 185
Figure 3 SEM photographs of Ca-alginate microspheres at different magnifications; (a) 140X
magnification, (b) 630X magnification, (c) 7800X magnification, (d) 13500X magnification.
2. GMO-Ca-alginate Microsphere characterization
2.1. Morphology observation
The microspheres prepared with GMO/alginate were examined as shown in SEM photographs
Figure (4). The Alginate:GMO ratio significantly affected the particle shape and morphology.
Particles with low GMO contents (1:0.25) were spherical in shape with white-doted surface and
average diameter of 35.2 μm ± 2.4μm Figure (4a,b&c). With increasing GMO contents (1:0.5,
0.75, &1), microparticles become more flattened, collapsed and larger in size (40-66 μm
average diameter) Figure (4d,e&f). This size increase may be related to higher alginate network
density produced by increased GMO concentration and thus reduced homogenization
efficiency.
Research Article CODEN: IJPRNK IMPACT FACTOR: 4.278 ISSN: 2277-8713 Amir Ibrahim Mohamed, IJPRBS, 2014; Volume 3(5): 177-193 IJPRBS
Available Online at www.ijprbs.com 186
Figure 4 SEM photographs of GMO-Ca-alginate microspheres with different Alginate:GMO
w/w ratios of 1:0.25 (a,b&c), 1:0.5 (d), 1:0.75 (e), 1:1 (f).
2.2. In-vitro Degradation study
When Ca++ crosslinked alginate hydrogels are placed in PBS 7.4, the ion-exchange process
between the Ca++ ions presenting in the ‘‘egg-box’’ cavity of polyguluronate blocks and Na+ ions
of buffer solution is mainly responsible for the swelling/degradation behaviour of Ca-alginate
microspheres [13]. The degradation of Ca-alginate microspheres formed with different GMO
concentration at constant cross-linking conditions, were studied and the percentage of weight
loss of microspheres as a function of degradation time is presented in Figure (5). We observed
that the weight loss was faster at the beginning, and then the degradation ratio slowly
increased with incubation time. The mass loss of the microspheres in the early stage may be a
result of a lower molecular part of the alginate polymer dissolving into the degradation
medium, while in the later stage of degradation, the mass loss may be due to the bulk
hydrolysis [22]. The erosion of microsphers decreased significantly by GMO-cubosomes
addition as compared to blank Ca-alginate microspheres. The degradation rate decreases
obviously with increasing Alginate:GMO w/w ratios from 1:0.25 to 1:0.5 . Further increase in
GMO concentration leads to a slight decrease of the degradation rate. 50% weight loss was
Research Article CODEN: IJPRNK IMPACT FACTOR: 4.278 ISSN: 2277-8713 Amir Ibrahim Mohamed, IJPRBS, 2014; Volume 3(5): 177-193 IJPRBS
Available Online at www.ijprbs.com 187
reached at approximately 8hrs for 1:0.25 GMO containing microspheres as compared to 5.5hrs
for blank microspheres without cubosomes, indicating that the presence of cubosomes
increased the stability of Ca-alginate microspheres. These results may relate to that, increased
alginate viscosity with increased GMO concentration, produced a tighter network matrix that is
more resistant to erosion and degradation.
Figure 5 Degradation profiles of blank and GMO-loaded
Ca-alginate microspheres.
3. Drug loaded Ca-alginate microspheres Characterization
The scanning electronic micrographs of Clindamycin-alginate and Clindamycin-GMO-alginate
microspheres are shown in Figures (6&7). The average diameter and entrapment efficiency of
these microspheres were summarized in Table (1).
Figure (6) shows morphological features of Alginate:Clindamycin microspheres at different drug
ratios. With low drug concentrations (1:0.25, and 1:0.5); alginate microspheres were generally
spherical, with average diameter ranged from 6.7 μm to 15.7 μm which obviously smaller than
those of the blank alginate microspheres (24.8 μm). A significant more reduction in
microsphere size (from 5.5 μm to 3.8 μm) was noted by increasing Clindamycin concentrations
(from 1:0.75 to 1:1) which a combined with the appearance of many sub-micron particles
Figure (6c&d). At higher drug ratios (1:2, and 1:3) the microspheres become fused, collapsed,
and irregular in presence of scattered aggregates of the sub-micron particles Figure (6e&f). This
could be related to hydrophilic-lipophilic properties of lincosamide antibiotics include
clindamycin [23], which may affect the surfactant (Span 80) activity.
Figure (7) shows the SEM images of Clindamycin-GMO-Alginate microspheres with different
drug ratios. At low Clindamycin concentrations (1:0.25) microspheres were generally oval in
Research Article CODEN: IJPRNK IMPACT FACTOR: 4.278 ISSN: 2277-8713 Amir Ibrahim Mohamed, IJPRBS, 2014; Volume 3(5): 177-193 IJPRBS
Available Online at www.ijprbs.com 188
shape, with average diameter of 27.4± 3.7μm Figure (7a), which smaller than those of the blank
GMO-alginate microspheres (35.2 μm). The microspheres with more drug ratios (1:0.5, 1:0.75
and 1:1) were less spherical in shape with collapsed centre and many aggregates of the sub-
micron particles Figure (7b,c,&d). Higher drug ratios (1:2, and 1:3) leaded to irregular and fused
microspheres formation, Figure (7e&f) which proved Clindamycin surface active agent
properties.
Figure 6 SEM photographs showing the effect of Alginate:Clindamycin ratio on microspheres
morphology (a) 1:0.25, (b) 1:0.5, (c) 1:0.75, (d) 1:1, (e) 1:2, (f) 1:3 w/w Alginate:Clindamycin.
Figure 7 SEM photographs of Clindamycin-GMO-Alginate microspheres; (a) 1:0.25, (b) 1:0.5,
(c) 1:0.75, (d) 1:1, (e) 1:2, (f) 1:3 w/w Alginate:Clindamycin ratio.
Research Article CODEN: IJPRNK IMPACT FACTOR: 4.278 ISSN: 2277-8713 Amir Ibrahim Mohamed, IJPRBS, 2014; Volume 3(5): 177-193 IJPRBS
Available Online at www.ijprbs.com 189
The values of entrapment efficiency of Clindamycin-alginate, and Clindamycin-GMO-
Alginate microspheres were shown in Table (1). The higher entrapment efficiencies were
observed with low drug ratios (1:0.25 & 1:0.5) in both formulations ranging from 85.57 to
87.46% for Clindamycin-Alginate and from 92.63 to 94.40% for Clindamycin-GMO-alginate
microspheres. These high entrapment efficiency can be explained by the method of
microsphere preparation, which involve the dispersion of hydrophilic drug solution in an
organic phase (DCM) to form a w/o emulsion and thus inhibit drug diffusion into preparation
medium[17]. Increasing drug ratios (1:0.75, 1:1, 1:2, & 1:3) decreased the entrapment
efficiency suggesting that the quantity of polymer present becomes insufficient to entrap the
hydrophilic drug. In addition, the porosity of alginate gel microspheres could be responsible of
the fast release of small molecular weight Clindamycin during the washing step [20]. The
entrapment efficiency of GMO-alginate microspheres was significantly higher than those of
conventional alginate microspheres at all Clindamycin-drug ratios. This result indicated that the
addition of GMO caused the formation of a core barrier that reduced drug leakage during
preparation and washing process. Moreover, GMO highly increase the internal structure
density of alginate matrix, and thus smaller pore channels for drug to diffuse out.
Table 1 The effect of Alginate/GMO:Clindamycin ratio on Particle Size and Entrapment
Efficiency.
Formulation
Composition (mg) Average diameter (μm)
Entrapment efficiency (%)
Alginate GMO Clindamycin
Blank Ca-alginate 400 -- -- 24.8 ± 3.7 -- Alginate – Clindamycin 1:0.25 1:0.50 1:0.75 1:1 1:2 1:3
400 400 400 400 400 400
-- -- -- -- -- --
100 200 300 400 800 1200
15.7± 2.1 6.7± 2.2 5.5± .2.3 3.8± 1.4 fused fused
85.57± 2.5 87.46± 1.3 83.72± 1.1 81.36± 1.6 79.76± 1.4 77.83± 2.1
Blank GMO-Ca-alginate 400 100 -- 35.2 ± 2.4 --
Alginate -GMO- Clindamycin 1:0.25 1:0.50 1:0.75 1:1 1:2 1:3
400 400 400 400 400 400
100 100 100 100 100 100
100 200 300 400 800 1200
27.4± 3.7 23.2± 2.6 irregular irregular fused fused
94.40± 5.4 92.63± 4.2 87.45± 3.7 83.15± 3.5 80.21± 4.6 79.42± 3.2
Research Article CODEN: IJPRNK IMPACT FACTOR: 4.278 ISSN: 2277-8713 Amir Ibrahim Mohamed, IJPRBS, 2014; Volume 3(5): 177-193 IJPRBS
Available Online at www.ijprbs.com 190
Considering the criteria of microspheres morphology, and entrapment efficiency; (1:0.25) w/w
Clindamycin-GMO-alginate microspheres was selected as optimum formulation for further
studies.
4. Drug-release studies
Figure (8) shows the release profiles of Clindamycin pure drug, Clindamycin-alginate, and
Clindamycin-GMO-alginate microspheres using the Dialysis bag method at pH 1.2, 4.5, and 7.4.
Being soluble in water, Clindamycin pure drug showed approximately total release (99.68%)
within 3hrs while, the conventional Ca-alginate microspheres showed 73.52% release within
3hrs. These quick releases could be attributed to drug hydrophilicity, and/or the removal of the
cross-linker bivalent cation, Calcium, from the alginate microspheres by monovalent cations,
such as Sodium or Potassium contained in phosphate buffers [24]. Addition of GMO dispersion
was shown to sustain drug release for a longer period of time (only 20.73% cumulative release
within 3hrs), which attributed to water uptake of GMO and formation of cubic phase that is
highly viscous and acts as a rate-limiting factor in drug release. Moreover, the release profile
from GMO-alginate microspheres showed a marked increase in drug release rate at pH (7.4) in
compared with very slow release at pH (1.2), which proved the pH effect on alginate release
properties. Many reports provided that Ca-alginate hydrogel shrinks at low pH, leading to a
much narrower pore size network for drug to diffuse out through; and swells at higher pH,
which broaden the network pore size and accelerate drug diffusion [20, 24]. Lipase digestion
medium has another effect on the release profile from GMO-alginate microspheres as shown in
Figure (8). A complete drug released (99.66%) was reached within 12.5 hrs in presence of lipase
enzyme compared to 99.58% cumulative release after 23hrs without lipase, which concluded
that digestive enzymes can obviously affected the drug release from our designing GMO-
alginate microspheres.
Figure 8 Release profiles of Clindamycin from GMO-Alginate microspheres.
Research Article CODEN: IJPRNK IMPACT FACTOR: 4.278 ISSN: 2277-8713 Amir Ibrahim Mohamed, IJPRBS, 2014; Volume 3(5): 177-193 IJPRBS
Available Online at www.ijprbs.com 191
CONCLUSION
In this study, a new kind of microparticle was prepared based on GMO- cubic phase dispersions
and Alginate using emulsification and cross-linking. These spherical particles had uniform
structure, confined size distribution, satisfactory entrapment efficiency, and acceptable
sustained release properties. (1:0.25) w/w Alginate-GMO microspheres showed a remarkable
entrapment efficiency (>94%) and prolonged Clindamycin release (>12hrs).This type of
microparticle matrix may have significant advantages for Ca-alginates microspheres controlled
release properties.
REFERENCES
1. Shah JC, Sadhale Y, Chilukuri DM. Cubic phase gels as drug delivery systems. Advanced Drug
Delivery Reviews. 2001;47:229-50.
2. Patel PV, Patel JB, Dangar RD, Patel KS, Chauhan KN. Liquid Crystal Drug Delivery System.
International Journal of Pharmaceutical and Applied Sciences. 2010;1(1):118-23.
3. Sagalowicz L, Mezzenga R, Leser ME. Investigating reversed liquid crystalline mesophases.
Current Opinion in Colloid & Interface Science. 2006;11(4):224-9.
4. Spicer PT. Progress in liquid crystalline dispersions: Cubosomes. Current Opinion in Colloid &
Interface Science. 2005;10(5-6):274-9.
5. Kojarunchitta T, Hooka S, Rizwanb S, Radesa T, Baldursdottir S. Development and
characterisation of modified poloxamer 407 thermoresponsive depot systems containing
cubosomes. International journal of pharmaceutics. 2011;408:20–6.
6. Lian R, Lu Y, Qi J, Tan Y, Niu M, Guan P, et al. Silymarin glyceryl monooleate/poloxamer 407
liquid crystalline matrices: physical characterization and enhanced oral bioavailability. AAPS
PharmSciTech. 2011;12(4):1234-40. Epub 2011/09/29.
7. Boyd BJ, Khoo SM, Whittaker DV, Davey G, Porter CJ. A lipid-based liquid crystalline matrix
that provides sustained release and enhanced oral bioavailability for a model poorly water
soluble drug in rats. International journal of pharmaceutics. 2007;340(1-2):52-60. Epub
2007/05/01.
8. Sheikhloie H, Farhadi K. Spectrophotometric determination of Dalacin phosphate from
formulations using reduce atomic absorption of calcium ion by phosphate. J Iran Chem Res.
2010;3:65-70.
9. Vukomanovic M, Skapin SD, Poljansek I, Zagar E, Kralj B, Ignjatovic N, et al. Poly(D,L-lactide-
co-glycolide)/hydroxyapatite core-shell nanosphere. Part 2: Simultaneous release of a drug and
a prodrug (clindamycin and clindamycin phosphate). Colloids and surfaces B, Biointerfaces.
2011;82(2):414-21. Epub 2010/10/19.
Research Article CODEN: IJPRNK IMPACT FACTOR: 4.278 ISSN: 2277-8713 Amir Ibrahim Mohamed, IJPRBS, 2014; Volume 3(5): 177-193 IJPRBS
Available Online at www.ijprbs.com 192
10. Wynalda MA, Hultzler JM, Koets MD, Podoll T, Wienkers LC. In vitro metabolism of
clindamycin in human liver and intestinal microsomes. Drug metabolism and disposition.
2003;31(7):878-87.
11. Platzer DJ, White BA. Development and validation of a gradient HPLC method for the
determination of clindamycin and related compounds in a novel tablet formulation. Journal of
pharmaceutical and biomedical analysis. 2006;41(1):84-8. Epub 2005/11/22.
12. Puttipipatkhachorn S, Pongjanyakul T, Priprem A. Molecular interaction in alginate beads
reinforced with sodium starch glycolate or magnesium aluminum silicate, and their physical
characteristics. International journal of pharmaceutics. 2005;293(1-2):51-62. Epub 2005/03/22.
13. Gao C, Liu M, Chen J, Zhang X. Preparation and controlled degradation of oxidized sodium
alginate hydrogel. Polymer Degradation and Stability. 2009;94(9):1405-10.
14. Moebusa K, Siepmannb J, Bodmeiera R. Alginate–poloxamer microparticles for controlled
drug delivery to mucosal tissue. European Journal of Pharmaceutics and Biopharmaceutics.
2009;72:42-53.
15. Sun J, Tan H. Alginate-Based Biomaterials for Regenerative Medicine Applications.
Materials. 2013;6(4):1285-309.
16. Rizwan SB, Assmus D, Boehnke A, Hanley T, Boyd BJ, Rades T, et al. Preparation of
phytantriol cubosomes by solvent precursor dilution for the delivery of protein vaccines.
European journal of pharmaceutics and biopharmaceutics : official journal of
Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV. 2011;79(1):15-22. Epub
2011/01/18.
17. Lemoine D, Wauters F, Bouchend’homme S, Preat V. Preparation and characterization of
alginate microspheres containing a model antigen. International journal of pharmaceutics.
1998;176:9-19.
18. Tian JY, Sun XQ, Chen XG. Formation and oral administration of alginate microspheres
loaded with pDNA coding for lymphocystis disease virus (LCDV) to Japanese flounder. Fish &
shellfish immunology. 2008;24(5):592-9. Epub 2008/03/11.
19. Nograles N, Abdullah S, Shamsudin MN, Billa N, Rosli R. Formation and characterization of
pDNA-loaded alginate microspheres for oral administration in mice. Journal of bioscience and
bioengineering. 2011;113(2):133-40. Epub 2011/11/19.
20. Wei L, Cai C, Lin J, Wang L, Zhang X. Degradation controllable biomaterials constructed from
lysozyme-loaded Ca-alginate microparticle/chitosan composites. Polymer. 2011;52(22):5139-
48.
Research Article CODEN: IJPRNK IMPACT FACTOR: 4.278 ISSN: 2277-8713 Amir Ibrahim Mohamed, IJPRBS, 2014; Volume 3(5): 177-193 IJPRBS
Available Online at www.ijprbs.com 193
21. Kotikalapudi LS, Adepu L, VijayaRatna J, Diwan PV. Formulation and invitro characterization
of domperidone loaded solid lipid nanoparticles. Int J Pharm Biomed Res. 2012;3(1):22-9.
22. Zhou S, Deng X, Li X. Investigation on a novel core-coated microspheres protein delivery
system. . Journal of Controlled Release. 2001;75:27-36.
23. Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient.
Critical care medicine. 2009;37(3):840-51; quiz 59. Epub 2009/02/25.
24. Ghosal K, Ray SD. Alginate/hydrophobic HPMC (60M) particulate systems: New matrix for
site specific and controlled drug delivery. Brazilian Journal of Pharmaceutical Sciences. 2011;
47(4): 834-44.